Correlation Between Abdominal Fat Distribution and Serum Uric Acid in Patients Recently Diagnosed with Type 2 Diabetes

References

• Atak BM, Kocak MZ, Savli H, et al. Serum uric acid level is associated with type 2 diabetes mellitus and diabetic regulation. Exper Bio Res. 2018;1(4):135–139. doi:10.30714/j-ebr.2018443416
   Google Scholar
• Kocak MZ, Aktas G, Duman TT, et al. Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy? Rev Assoc Med Bras. 2019;65:1155–1160. doi:10.1590/1806-9282.65.9.1156
   PubMed Web of Science ®Google Scholar
• Chien K-L, Chen M-F, Hsu H-C, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008;54(2):310–316. doi:10.1373/clinchem.2007.095190
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67:549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65:9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Hsia Y, Neubert AC, Rani F, et al. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol. 2009;67(2):242–249. doi:10.1111/j.1365-2125.2008.03347.x
   PubMed Web of Science ®Google Scholar
• Shield J, Lynn R, Wan KC, et al. Management and 1 year outcome for UK children with type 2 diabetes. Arch Dis Child. 2009;94(3):206–209. doi:10.1136/adc.2008.143313
   PubMed Web of Science ®Google Scholar
• Yokokawa H, Fukuda H, Saita M, et al. An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects. Diabetol Metab Syndr. 2021;13:1–10. doi:10.1186/s13098-021-00646-3
   PubMed Web of Science ®Google Scholar
• Patel P, Abate N. Body fat distribution and insulin resistance. Nutrients. 2013;5(6):2019–2027. doi:10.3390/nu5062019
   PubMed Web of Science ®Google Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–846. doi:10.1038/nature05482
   PubMed Web of Science ®Google Scholar
• Adnan E, Rahman IA, Faridin H. Relationship between insulin resistance, metabolic syndrome components and serum uric acid. Diabetes Metab Syndr. 2019;13(3):2158–2162.
   PubMed Web of Science ®Google Scholar
• Hirayama S, Hori A, Isshiki M, et al. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men. J Clin Lipidol. 2020;14(4):522–530. doi:10.1016/j.jacl.2020.06.003
   PubMed Web of Science ®Google Scholar
• Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019;20(1):5–9. doi:10.1111/pedi.12787
   PubMed Web of Science ®Google Scholar
• Barroso T, Conway F, Emel S, et al. Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls. Anna Gastroenterol. 2018;31(5):566. doi:10.20524/aog.2018.0280
   PubMed Web of Science ®Google Scholar
• Hinnouho G-M, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2015;36(9):551–559. doi:10.1093/eurheartj/ehu123
   PubMed Web of Science ®Google Scholar
• Hu X, Rong S, Wang Q, et al. Association between plasma uric acid and insulin resistance in type 2 diabetes: a Mendelian randomization analysis. Diabetes Res Clin Pract. 2021;171:108542. doi:10.1016/j.diabres.2020.108542
   PubMed Web of Science ®Google Scholar
• Katsiki N, Papanas N, Fonseca V, et al. Uric acid and diabetes: is there a link? Curr Pharm Des. 2013;19(27):4930–4937. doi:10.2174/1381612811319270016
   PubMed Web of Science ®Google Scholar
• Tang X, Yan X, Zhou H, et al. Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes. Chin Med J. 2022;135(21):2554–2562. doi:10.1097/CM9.0000000000002075
   PubMed Web of Science ®Google Scholar
• Biradar MI, Chiang K-M, Yang H-C, et al. The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components. Int J Obes. 2020;44(4):865–874. doi:10.1038/s41366-019-0487-9
   Web of Science ®Google Scholar
• Mauer M, Doria A. Uric acid and diabetic nephropathy risk. Uric Acid Chron Kidney Dis. 2018;192:103–109.
   Google Scholar
• Ali N, Rahman S, Islam S, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19:1–7. doi:10.1186/s12872-019-1026-2
   PubMed Web of Science ®Google Scholar
• Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Rev. 2010;11(1):11–18. doi:10.1111/j.1467-789X.2009.00623.x
   PubMed Web of Science ®Google Scholar
• Sahinturk Y, Kucukseymen S, Avci R, et al. Visceral fat index: a novel predictor for coronary collateral circulation. Arch Endocrinol Metab. 2020;64:150–158. doi:10.20945/2359-3997000000218
   PubMed Web of Science ®Google Scholar
• Taniguchi Y, Kurokawa Y, Takahashi T, et al. Impacts of preoperative psoas muscle mass and visceral fat area on postoperative short-and long-term outcomes in patients with gastric cancer. World J Surg. 2021;45:815–821. doi:10.1007/s00268-020-05857-9
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Ben-David N, Shibanov L, et al. Visceral adiposity but not subcutaneous fat associated with improved outcome of patients with acute cholecystitis. J Surg Res. 2018;225:15–20. doi:10.1016/j.jss.2017.11.053
   PubMed Web of Science ®Google Scholar
• Di Bonito P, Valerio G, Licenziati MR, et al. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. J Endocrinol Invest. 2020;43:461–468. doi:10.1007/s40618-019-01130-6
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Al-Attas OS, Wani K, et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in Saudi type 2 diabetic patients. Sci Rep. 2017;7(1):12104. doi:10.1038/s41598-017-12085-0
   PubMed Web of Science ®Google Scholar
• Zong J, Sun Y, Zhang Y, et al. Correlation between serum uric acid level and central body fat distribution in patients with type 2 diabetes. Diabet Meta Synd Obes. 2020;Volume 13:2521–2531. doi:10.2147/DMSO.S260891
   Google Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010;17(4):332–341. doi:10.5551/jat.3939
   PubMed Web of Science ®Google Scholar
• Adachi S-I, Yoshizawa F, Yagasaki K. Hyperuricemia in type 2 diabetic model KK-A y/Ta mice: a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels. BMC Res Notes. 2017;10:1–5. doi:10.1186/s13104-017-2897-x
   PubMedGoogle Scholar
• Ghasemi A. Uric acid‐induced pancreatic β-cell dysfunction. BMC Endocr Disord. 2021;21(1):1–5. doi:10.1186/s12902-021-00698-6
   PubMed Web of Science ®Google Scholar
• Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
   PubMed Web of Science ®Google Scholar